Integrating iStent inject® W into Your Practice
Conventional thinking about glaucoma management has commonly reserved surgery for advanced disease. Today, thanks to the advancement of Trabecular Micro-Bypass surgery, that perspective has evolved, and surgery with iStent inject® W has become a valuable option for many practices just like yours. Here are just a few reasons why you should consider offering the benefits of iStent inject® W to your patients.
Easy Adoption into Your Practice
Clinical studies show that Glaukos trabecular micro-bypass technologies – such as iStent inject® W – are effective when implanted alone or in conjunction with cataract surgery in those subjects who require intraocular pressure reduction.1-2
1. Hengerer FH. Personal Experience with Second-Generation Trabecular Micro-Bypass Stents in Combination with Cataract Surgery in Patients with Glaucoma: 3-Year Follow-up. ASCRS 2018 Presentation.
2. Samuelson TW. Randomized evaluation of the trabecular micro-bypass stent with phacoemulsification in patients with glaucoma and cataract. Ophthalmology. March 2011;118(3):459-467.
Glaucoma Prevalence in the Cataract Population
Ideal iStent inject® W patients are already in your practice! Glaukos can provide educational materials to you, your staff and your patients to help you offer this opportunity to all of your glaucoma candidates with open-angle glaucoma, either at the time of cataract surgery or as a stand-alone procedure.
Offer Complete Treatment Options
With the rapid introduction of advanced technologies and techniques, the role of the surgeon continues to expand. Furthermore, ophthalmologists are looking for a safe and minimally invasive surgical alternative that can provide earlier intervention for open-angle glaucoma. iStent inject® W provides both, enabling you to offer an innovative treatment to your patients with open-angle glaucoma.
Looking for more information on iStent inject® W?
We’re here to answer questions and provide any additional information you may need.Contact Us